Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Evans

Showing results (41-50 of 208) with videos related to

Pageof 21
Sort By:
BJU International|January 15, 2008
Non-surgical management of multicystic dysplastic kidneyAngelo J Cambio, Christopher P Evans, Eric A Kurzrock
BJU International|November 12, 2015
Urethral recurrence after cystectomy: current preventative measures, diagnosis and managementYvonne Chan, Patrick Fisher, Derya Tilki, et al.
The Canadian Journal of Urology|February 7, 2008
Managing prostate cancer: the role of hormone therapyMichelle L Ramirez, Thomas E Keane, Christopher P Evans
BMC Medicine|September 3, 2015
Targeting molecular resistance in castration-resistant prostate cancerThenappan Chandrasekar, Joy C Yang, Allen C Gao, et al.
Urology Practice|August 10, 2023
Active Surveillance for Prostate Cancer under the Patient Protection and Affordable Care ActLindsay Yuh, Marc A Dall'Era, David F Penson, et al.
BJU International|March 30, 2005
An evidence-based approach to understanding the pharmacological class effect in the management of prostatic diseasesChristopher P Evans, Neil Fleshner, John M Fitzpatrick, et al.
Translational Andrology and Urology|January 28, 2016
Mechanisms of resistance in castration-resistant prostate cancer (CRPC)Thenappan Chandrasekar, Joy C Yang, Allen C Gao, et al.
Current Opinion in Urology|August 12, 2005
Is the use of anything but MVAC justified in the evidence-based medicine era?Joon-ha Ok, Angelo Cambio, Primo N Lara, et al.
Urologic Oncology|June 18, 2014
The role of microRNA in castration-resistant prostate cancerWilliam Thieu, Derya Tilki, Ralph de Vere White, et al.
Prostate Cancer and Prostatic Diseases|August 18, 2018
Non-metastatic castration resistant prostate cancer: a review of current and emerging medical therapiesSigfred Ian R Alpajaro, Jerad A K Harris, Christopher P Evans
Pageof 21

Showing results (41-50 of 208) with videos related to

Sort By:
Pageof 21
BJU International|January 15, 2008
Non-surgical management of multicystic dysplastic kidneyAngelo J Cambio, Christopher P Evans, Eric A Kurzrock
BJU International|November 12, 2015
Urethral recurrence after cystectomy: current preventative measures, diagnosis and managementYvonne Chan, Patrick Fisher, Derya Tilki, et al.
The Canadian Journal of Urology|February 7, 2008
Managing prostate cancer: the role of hormone therapyMichelle L Ramirez, Thomas E Keane, Christopher P Evans
BMC Medicine|September 3, 2015
Targeting molecular resistance in castration-resistant prostate cancerThenappan Chandrasekar, Joy C Yang, Allen C Gao, et al.
Urology Practice|August 10, 2023
Active Surveillance for Prostate Cancer under the Patient Protection and Affordable Care ActLindsay Yuh, Marc A Dall'Era, David F Penson, et al.
BJU International|March 30, 2005
An evidence-based approach to understanding the pharmacological class effect in the management of prostatic diseasesChristopher P Evans, Neil Fleshner, John M Fitzpatrick, et al.
Translational Andrology and Urology|January 28, 2016
Mechanisms of resistance in castration-resistant prostate cancer (CRPC)Thenappan Chandrasekar, Joy C Yang, Allen C Gao, et al.
Current Opinion in Urology|August 12, 2005
Is the use of anything but MVAC justified in the evidence-based medicine era?Joon-ha Ok, Angelo Cambio, Primo N Lara, et al.
Urologic Oncology|June 18, 2014
The role of microRNA in castration-resistant prostate cancerWilliam Thieu, Derya Tilki, Ralph de Vere White, et al.
Prostate Cancer and Prostatic Diseases|August 18, 2018
Non-metastatic castration resistant prostate cancer: a review of current and emerging medical therapiesSigfred Ian R Alpajaro, Jerad A K Harris, Christopher P Evans
Pageof 21